sodium thiosulfate has been researched along with pamidronate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alvarez, CL; Estifan Ksabji, J; Fernández Cañabate, S; Ortega Valin, L | 1 |
| Bellasi, A; Feriozzi, S; Gomes, V; Massimetti, C; Modoni, A | 1 |
1 review(s) available for sodium thiosulfate and pamidronate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for sodium thiosulfate and pamidronate
| Article | Year |
|---|---|
Sodium thiosulfate and pamidronate for treatment of calciphylaxis: case report.
Topics: Administration, Intravenous; Aged; Calciphylaxis; Chelating Agents; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Pamidronate; Renal Dialysis; Thiosulfates; Treatment Outcome | 2018 |
Multifaceted approach to a rare clinical case of calciphylaxis in a renal transplant recipient.
Topics: Aged; Anticoagulants; Bone Density Conservation Agents; Calciphylaxis; Chelating Agents; Combined Modality Therapy; Diabetes Mellitus; Female; Humans; Kidney Transplantation; Leg Ulcer; Livedo Reticularis; Pamidronate; Rare Diseases; Risk Factors; Thiosulfates; Warfarin | 2019 |